[Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)].
Fifty patients with CIDP were treated with cortico-steroids (CS), plasmapheresis (PP) and human immunoglobulin (IG). Objective improvements in strength and in nerve conduction occurred in 53% of the patients after CS. In 50% of the non-responders to CS showed objective improvements after PP, and 40% of them responded to IG. Complete remission was achieved in only one patient. Around 15% of the patients showed poor response to any treatments. Azathioprine combined with CS induced little objective improvements.
Baba
M
M
Department of Neurology, Hirosaki University School of Medicine.
Ogawa
M
M
Matsunaga
M
M
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002648:Child; D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000628:therapy*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis
D000305:Adrenal Cortex Hormones; D007136:Immunoglobulins